City Holding Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810K Sell
14,061
-1,206
-8% -$69.3K 0.09% 160
2026
Q1
$926K Buy
15,267
+5,650
+59% +$329K 0.12% 153
2025
Q4
$519K Sell
9,617
-1,878
-16% -$90.3K 0.06% 185
2025
Q3
$518K Sell
11,495
-774
-6% -$36.1K 0.07% 186
2025
Q2
$568K Sell
12,269
-1,114
-8% -$54.7K 0.07% 187
2025
Q1
$816K Buy
13,383
+1,700
+15% +$99.1K 0.12% 166
2024
Q4
$661K Sell
11,683
-1,809
-13% -$101K 0.09% 178
2024
Q3
$698K Sell
13,492
-987
-7% -$46.3K 0.1% 175
2024
Q2
$601K Sell
14,479
-1,931
-12% -$86.4K 0.09% 181
2024
Q1
$890K Sell
16,410
-2,455
-13% -$125K 0.13% 154
2023
Q4
$968K Sell
18,865
-1,878
-9% -$98.6K 0.16% 145
2023
Q3
$1.2M Sell
20,743
-1,419
-6% -$86.9K 0.21% 113
2023
Q2
$1.42M Sell
22,162
-365
-2% -$24.5K 0.24% 105
2023
Q1
$1.56M Buy
22,527
+100
+0.4% +$7.05K 0.28% 100
2022
Q4
$1.61M Sell
22,427
-1,225
-5% -$92.4K 0.3% 89
2022
Q3
$1.68M Sell
23,652
-1,100
-4% -$79.8K 0.33% 86
2022
Q2
$1.91M Sell
24,752
-1,720
-6% -$131K 0.36% 81
2022
Q1
$1.93M Sell
26,472
-95
-0.4% -$6.38K 0.31% 89
2021
Q4
$1.82M Sell
26,567
-5,445
-17% -$319K 0.3% 91
2021
Q3
$1.89M Sell
32,012
-10,148
-24% -$668K 0.32% 88
2021
Q2
$2.82M Sell
42,160
-8,050
-16% -$525K 0.5% 64
2021
Q1
$3.17M Sell
50,210
-4,990
-9% -$310K 0.6% 47
2020
Q4
$3.42M Sell
55,200
-9,197
-14% -$566K 0.72% 41
2020
Q3
$3.88M Sell
64,397
-113
-0.2% -$6.8K 0.88% 33
2020
Q2
$3.79M Buy
64,510
+2,949
+5% +$176K 0.94% 30
2020
Q1
$3.43M Buy
61,561
+3,581
+6% +$219K 1.04% 25
2019
Q4
$3.72M Buy
57,980
+6,000
+12% +$344K 0.88% 36
2019
Q3
$2.63M Sell
51,980
-110
-0.2% -$5.17K 0.68% 52
2019
Q2
$2.36M Buy
52,090
+2,326
+5% +$108K 0.64% 54
2019
Q1
$2.37M Buy
49,764
+6,766
+16% +$337K 0.67% 53
2018
Q4
$2.23M Buy
42,998
+890
+2% +$47.8K 0.73% 46
2018
Q3
$2.61M Buy
42,108
+792
+2% +$47K 0.75% 44
2018
Q2
$2.29M Buy
41,316
+2,610
+7% +$141K 0.7% 53
2018
Q1
$2.45M Sell
38,706
-274
-0.7% -$17.6K 0.78% 46
2017
Q4
$2.39M Sell
38,980
-885
-2% -$55.4K 0.76% 48
2017
Q3
$2.54M Sell
39,865
-525
-1% -$30.7K 0.85% 39
2017
Q2
$2.25M Buy
40,390
+7,705
+24% +$419K 0.79% 42
2017
Q1
$1.78M Buy
32,685
+4,410
+16% +$242K 0.67% 48
2016
Q4
$1.65M Buy
28,275
+3,577
+14% +$196K 0.64% 54
2016
Q3
$1.33M Buy
24,698
+4,320
+21% +$277K 0.58% 63
2016
Q2
$1.5M Sell
20,378
-148
-0.7% -$10.5K 0.67% 49
2016
Q1
$1.31M Buy
20,526
+225
+1% +$14.2K 0.66% 54
2015
Q4
$1.4M Buy
20,301
+197
+1% +$13K 0.72% 50
2015
Q3
$1.19M Sell
20,104
-1,549
-7% -$98.3K 0.65% 57
2015
Q2
$1.44M Sell
21,653
-380
-2% -$25K 0.73% 50
2015
Q1
$1.42M Sell
22,033
-407
-2% -$25.5K 0.73% 51
2014
Q4
$1.32M Sell
22,440
-227
-1% -$12.8K 0.7% 52
2014
Q3
$1.16M Sell
22,667
-375
-2% -$18.7K 0.64% 58
2014
Q2
$1.17M Buy
23,042
+4,225
+22% +$208K 0.67% 54
2014
Q1
$978K Sell
18,817
-300
-2% -$16K 0.6% 62
2013
Q4
$1.02M Buy
+19,117
New +$974K 0.64% 56

Other funds holding BMY

City Holding Co's BMY Position: Q2 2026 in Review

City Holding Co reduced its Bristol-Myers Squibb (BMY) stake by 7.9% in Q2 2026, selling an estimated $69.3K and leaving 14,061 shares worth $810K. The position accounts for 0.09% of the portfolio, ranked #160.

City Holding Co first reported a position in BMY in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.88M in Q3 2020. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • City Holding Co held 14,061 shares of Bristol-Myers Squibb worth $810K as of Q2 2026.
  • City Holding Co sold 1,206 Bristol-Myers Squibb shares in Q2 2026, an estimated $69.3K.
  • Bristol-Myers Squibb made up 0.09% of City Holding Co's portfolio in Q2 2026, its #160 holding.
  • City Holding Co first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 51 quarters since.
  • City Holding Co's Bristol-Myers Squibb position peaked at $3.88M in Q3 2020.
  • 565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.